No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study-Reference-Cited by-同舟云学术

No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study

Published:2016-02-05 Issue:2 Volume:173 Page:236-244
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Jakobsen Lasse H.¹²,Hutchings Martin³,de Nully Brown Peter³,Linderoth Johan⁴,Mylam Karen J.⁵,Molin Daniel⁶,Johnsen Hans E.¹²⁷,Bøgsted Martin¹²⁷⁸,Jerkeman Mats⁴,El-Galaly Tarec C.¹²⁷

Affiliation:

1. Department of Haematology; Aalborg University Hospital; Aalborg Denmark

2. Department of Clinical Medicine; Aalborg University; Aalborg Denmark

3. Department of Haematology; Rigshospitalet; Copenhagen University Hospital; Copenhagen Ø Denmark

4. Department of Oncology; Lund University Hospital; Lund Sweden

5. Department of Haematology; Odense University Hospital; Odense Denmark

6. Experimental and Clinical Oncology; Department of Genetics and Pathology; Uppsala University; Uppsala Sweden

7. Clinical Cancer Research Unit; Aalborg University Hospital; Aalborg Denmark

8. Unit of Clinical Biostatistics; Department of Clinical Medicine; Aalborg University; Aalborg Denmark

Funder

North Denmark Region

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13943/fullpdf

Reference46 articles.

1. Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry;Abrahamsson;Leukemia & Lymphoma,2011

2. Patients' and physicians' roles in detecting recurrent Hodgkin lymphoma following complete remission;Bestawros;Annals of Oncology,2012

3. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage Hodgkin's lymphoma;Borchmann;Journal of Clinical Oncology,2011

4. Hodgkin lymphoma: response assessment by revised International Workshop Criteria;Brepoels;Leukemia & Lymphoma,2007

5. Brown , P. Jørgensen , J. Munksgaard , L. Petersen , B.A. Pedersen , M. Jensen , P. Klausen , T. 2012 Annual Report of The Danish Lymphoma Group 2011 http://www.lymphoma.dk/picture/upload/Aarsrapport_2011_ver_1_3.pdf

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Outcome of Hodgkin Lymphoma With Reference to Prognostic Markers;Cureus;2022-08-26

2. Investigating early progression of Hodgkin lymphoma in a two-center analysis;Journal of the Formosan Medical Association;2022-07

3. Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline;British Journal of Haematology;2022-02-22

4. The role of surveillance computed tomography in patients with follicular lymphoma;Therapeutic Advances in Hematology;2022-01

5. Hodgkin Lymphoma: Recent Progress in Overall Management;Lymphoma;2021-12-27